FDA approves prescription of overdose antidote for heroin

The Food and Drug Administration on Thursday approved an easy-to-use device that automatically injects the right dose of an overdose antidote for heroin or other powerful painkillers in a class called opioids. The antidote has previously been administered by syringe in ambulances or emergency rooms, but doctors can now prescribe Evzio, a device containing naloxone, to family members or caregivers of those taking certain drugs or struggling with abuse. 

Opioids include legal prescription painkillers, such as OxyContin and Vicodin, as well as illegal street drugs like heroin. With the rise in drug overdose deaths, there has been a growing push to equip more people with protection.

The FDA said Evzio's design makes it easy for anyone to administer. Once Evzio is turned on, it provides verbal instructions, much like defibrillators that laymen frequently use to help people who collapse with cardiac arrest. It is about the size of a credit card or small cellphone.

Still uncertain is how much the antidote will cost. Executives of the drug's manufacturer, kaleo, Inc., of Richmond, Va., said it is too soon to say, but they are working with health insurers to get broad coverage.

The antidote is not a substitute for immediate medical care, the FDA said, as anyone who has overdosed will need additional treatment.

Eric Edwards of kaleo says the antidote is intended not just for heroin or prescription drug addicts, but also for people who have accidental overdoses, unexpected drug interactions or are on very high doses of the drugs. People who overdose may suffer slower breathing or heart rates or loss of consciousness.

FDA Commissioner Margaret Hamburg said in a news release that 16,000 people die every year due to opioid-related overdoses, and that drug overdose deaths are now the leading cause of injury death in the United States, surpassing motor vehicle crashes. She said the increase in overdose deaths has largely been driven by prescription drug overdoses.

The announcement follows several state efforts to widen access to the antidote. At least 17 states and the District of Columbia now allow naloxone –commonly known by the brand name Narcan – to be distributed to the public. Some of those states allow for third parties, such as a family member or friend of an intravenous drug user, to be prescribed it. On Thursday, the state of New York announced that every state and local law enforcement officer will now carry syringes and inhalers of naloxone.

Police in Quincy, Mass., have been carrying naloxone nasal spray since 2010 and said in July 2013 that they used naloxone 179 times, reversing 170 of those overdoses – a 95 percent success rate.

Some have questioned the idea, however. Maine Gov. Paul LePage has opposed a bill that would allow health care professionals to prescribe it for caregivers and family members and allow more emergency responders to carry the drug, saying it could raise Medicaid costs. He vetoed a similar bill last year, arguing that it could provide a false sense of security that abusers are somehow safe if they have a prescription nearby.

Health and Human Services Secretary Kathleen Sebelius said that making the antidote more available is part of a comprehensive government strategy to reduce opioid addictions, along with educating the medical community about signs of possible problems and reducing illegal access to the drugs.

Attorney General Eric Holder also weighed in on heroin abuse Thursday, telling a Senate committee that the government needs to deal differently with the heroin epidemic than it did with the crack cocaine crisis decades ago, when police focused on large-scale arrests and imprisonment.

Holder said the government has a small window to prevent the heroin problem from getting "even more out of control than it already is," saying specialized drug courts within the criminal justice system are a good way to reduce the prison population.

The Associated Press